<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37814234</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Characterization and predictive risk scoring of long COVID in a south indian cohort after breakthrough COVID infection; a prospective single centre study.</ArticleTitle><Pagination><StartPage>670</StartPage><MedlinePgn>670</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">670</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08600-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">With the World Health Organization (WHO) declaring an end to the COVID-19 pandemic, the focus has shifted to understanding and managing long-term post-infectious complications. "Long COVID," characterized by persistent or new onset symptoms extending beyond the initial phase of infection, is one such complication. This study aims to describe the incidence, clinical features and risk profile of long COVID among individuals in a South Indian cohort who experienced post-ChAdOx1 n-Cov-2 vaccine breakthrough infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-centre hospital-based prospective observational study was conducted from October to December 2021. The study population comprised adult patients (&gt;&#x2009;18 years) with a confirmed COVID-19 diagnosis who had received at least a single dose of vaccination. Data was collected using a specially tailored questionnaire at week 2, week 6, and week 12 post-negative COVID-19 test. A propensity score based predictive scoring system was developed to assess the risk of long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 414 patients followed up in the study, 164 (39.6%) reported long COVID symptoms persisting beyond 6 week's post-infection. The presence of long COVID was significantly higher among patients above 65 years of age, and those with comorbidities such as Type II Diabetes Mellitus, hypertension, dyslipidemia, coronary artery disease, asthma, and cancer. Using backwards selection, a reduced model was developed, identifying age (OR 1.053, 95% CI 0.097-1.07, p&#x2009;&lt;&#x2009;0.001), hypertension (OR 2.59, 95% CI 1.46-4.59, p&#x2009;=&#x2009;0.001), and bronchial asthma (OR 3.7176, 95% CI 1.24-11.12, p&#x2009;=&#x2009;0.018) as significant predictors of long COVID incidence. A significant positive correlation was observed between the symptomatic burden and the number of individual comorbidities.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The significant presence of long COVID at 12 weeks among non-hospitalised patients underscores the importance of post-recovery follow-up to assess for the presence of long COVID. The predictive risk score proposed in this study may help identify individuals at risk of developing long COVID. Further research is needed to understand the impact of long COVID on patients' quality of life and the potential role of tailored rehabilitation programs in improving patient outcomes.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Pranav</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Chithira V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulirankal</LastName><ForeName>Kiran G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corley</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Weill Cornell, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edathadathil</LastName><ForeName>Fabia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infection Control and Epidemiology, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutjahr</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Research in Analytics and Technologies for Education (CREATE), Amrita Vishwa Vidyapeetham, Amritapuri, Kollam, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moni</LastName><ForeName>Merlin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyapalan</LastName><ForeName>Dipu T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. diputsmck@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidhyapeetham, Kochi, 682041, Kerala, India. diputsmck@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093742" MajorTopicYN="N">Breakthrough Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breakthrough infections</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37814234</ArticleId><ArticleId IdType="pmc">PMC10563355</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08600-6</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08600-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Declares End to COVID-19 as Global Health Emergency. https://sdg.iisd.org/news/who-declares-end-to-covid-19-as-global-health-emergency/. (accessed jul 2, 2023).</Citation></Reference><Reference><Citation>Yang C, Tebbutt SJ. Long COVID: the next public health crisis is already on its way. Lancet Reg Health&#x2013;Europe. 2023;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10006728</ArticleId><ArticleId IdType="pubmed">37131860</ArticleId></ArticleIdList></Reference><Reference><Citation>Post -COVID, Conditions. Information for Health Care Providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. (accessed sep 22, 2022).</Citation></Reference><Reference><Citation>Long COVID. terms and definitions development explained. https://www.covid.gov/longcovid/definitions. (accessed sep 23, 2022).</Citation></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y. Covid-19 and autoimmunity. Autoimmun rev. 2020;19(8):102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J, Shi L, Chen H, Wang X, Yang M, Yang J, Liu M, Yi X, Sun G. Containment strategy during the COVID-19 pandemic among three asian low and middle-income countries. J Global Health. 2022;12:05016. doi: 10.7189/jogh.12.05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05016</ArticleId><ArticleId IdType="pmc">PMC9123341</ArticleId><ArticleId IdType="pubmed">35596570</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YZ, Kuan CC. Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022;26:1770&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35302230</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell FM, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccines Immunotherapeutics. 2021;17(5):1317&#x2013;21. doi: 10.1080/21645515.2020.1827882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1827882</ArticleId><ArticleId IdType="pmc">PMC8078651</ArticleId><ArticleId IdType="pubmed">33141000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Roy P, Ravichandran M, Mandal S, Pal D, Das K, Gajjala A, Venkateshan M, Mishra B, Patro BK, Mohapatra PR, Subba SH. Long COVID following Omicron wave in Eastern India-A retrospective cohort study. J Med Virol. 2023;95(1):e28214. doi: 10.1002/jmv.28214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, Desai D, Trilangi PK, Chakraborty S, Begam NN, Bhattacharya B. Post COVID-19 sequelae: a prospective observational study from Northern India. Drug Discoveries &amp; Therapeutics; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>INSACOG: INDIAN SARS-COV-2 GENOMICS CONSORTIUM. https://dbtindia.gov.in/insacog. (accessed jan 2, 2022).</Citation></Reference><Reference><Citation>Davidson M. Rasch analysis of three versions of the Oswestry Disability Questionnaire. Man Therap. 2008;13(3):222&#x2013;31. doi: 10.1016/j.math.2007.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.math.2007.01.008</ArticleId><ArticleId IdType="pubmed">17363319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank JC, Couper J, Davies JB, O&#x2019;Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66(8):271&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">6450426</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank JC. Why are there different versions of the Oswestry disability index?: a review. J Neurosurgery: Spine. 2014;20(1):83&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24206036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25(22):2940&#x2013;53. doi: 10.1097/00007632-200011150-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200011150-00017</ArticleId><ArticleId IdType="pubmed">11074683</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Action Plan on Long COVID. https://www.covid.gov/assets/files/National-Research-Action-Plan-on-Long-COVID-08012022.pdf. (accessed on sep 2, 2022).</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post-COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization; 2021.</Citation></Reference><Reference><Citation>NICE COVID-19. rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/chapter/Context (accessed sep 2, 2022].</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: springer; 2001 Jan. p. 10.</Citation></Reference><Reference><Citation>Jimenez AE, Feghali J, Schilling AT, Azad TD. Deployment of clinical prediction models: a practical guide to nomograms and online calculators. InMachine Learning in Clinical Neuroscience: foundations and applications 2022 (pp. 101&#x2013;8). Springer International Publishing.</Citation><ArticleIdList><ArticleId IdType="pubmed">34862533</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiol (Cambridge Mass) 2010;21(1):128. doi: 10.1097/EDE.0b013e3181c30fb2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181c30fb2</ArticleId><ArticleId IdType="pmc">PMC3575184</ArticleId><ArticleId IdType="pubmed">20010215</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Team R, Core Team AR. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.</Citation></Reference><Reference><Citation>Chen Chen, Spencer R, Haupert L, Zimmermann Xu, Shi, Lars G, Fritsche B, Mukherjee. Global prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a Meta-analysis and systematic review. J Infect Dis. November 2022;226(9):1593&#x2013;607. 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N. Et alCharacterising long COVID: a living systematic reviewBMJ. Global Health. 2021;6:e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhiraja S, Aggarwal M, Wig R, Tyagi A, Mishra RS, Mahajan M, Kirtani J, Tickoo R, Bali S, Dewan A, Aggarwal R. Long-term Health Consequences of COVID-19 in hospitalized patients from North India: a follow-up study of upto 12 months. Medrxiv. 2021 Jun;28:2021&#x2013;06.</Citation></Reference><Reference><Citation>Daniel Ayoubkhani ML, Bosworth S, King, Koen B, Pouwels M, Glickman V, Nafilyan F, Zaccardi K, Khunti, Nisreen A, Alwan. A Sarah Walker, author notes: Open Forum Infectious Diseases, Volume 9, Issue 9, September 2022, ofac464, 10.1093/ofid/ofac464z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Elena Azzolini MD, PhD1; Riccardo Levi, MSc2; Riccardo Sarti, MSc2. et al JAMA. 2022;328(7):676&#x2013;8. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review Kin Israel Notarte,a Jesus Alfonso Catahay,b Jacqueline Veronica Velasco; eClinicalMedicine 2022;53: 101624 Published online xxx https://doi.org/10.1016/j. eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study; BMJ 2022;377: e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O&#x2019;Brien KK. Conceptualising Long COVID as an episodic health condition. BMJ Global Health. 2021;6:e007004. doi: 10.1136/bmjgh-2021-007004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-007004</ArticleId><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, Sheikh AAE, Khan AM, Khalid SN, Khan J, Nasrullah A, Sagheer S, Sheikh AB. COVID-19 vaccine and long COVID: a scoping review. Life (Basel) 2022;12(7):1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Researching COVID. to Enhance Recovery Initiative, Making progress toward recovery; https://recovercovid.org/research, Date accessed: July 10, 2022.</Citation></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, et al. Lancet Glob Health. 2022;10:e1247&#x2013;56. doi: 10.1016/S2214-109X(22)00286-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>